Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples

Clinical and Vaccine Immunology

Volumn 19, Issue 9, 2012, Pages 1452-1456

  De Greeff, Sabine C ^a   Teunis, Peter ^b   De Melker, Hester E ^a   Mooi, Frits R ^a   Notermans, Daan W ^a   Elvers, Bert ^a   Schellekens, Joop F P ^c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b EMORY UNIVERSITY   (United States)

^c Laboratory for Infectious Diseases   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ACELLULAR PERTUSSIS; ANTIBODY SPECIFICITY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLUSTER ANALYSIS; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR CLINICAL STUDY; PERTUSSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTITOXINS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; PERTUSSIS TOXIN; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERUM; WHOOPING COUGH; YOUNG ADULT;

EID: 84865955835     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00229-12     Document Type: Article

References (32)

1. Andre P, et al. 2008. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J. Clin. Microbiol. 46: 1672-1677. (Pubitemid 351657212)
2. Aoyama T, et al. 1997. Simple, speedy, sensitive, and specific serodiagnosis of pertussis by using a particle agglutination test. J. Clin. Microbiol. 35:1859-1861. (Pubitemid 27255675)
3. Baughman AL, et al. 2004. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin. Diagn. Lab. Immunol. 11:1045-1053. (Pubitemid 39540842)
4. Berbers GAM, Jones N. 2008. Serological surveillance of the effect of the changes to pertussis vaccines in the NIP from 2004 till 2008. Switch from whole cell to acellular vaccine in children of 1 year of age. National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
5. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE. 2005. Resurgence of pertussis in Europe. Pediatr. Infect. Dis. J. 24:761-765. (Pubitemid 41324882)
6. Chatterjee A, et al. 2007. A modified "cover your cough" campaign prevents exposures of employees to pertussis at a children's hospital. Am. J. Infect. Control. 35:489-491. (Pubitemid 47331963)
7. Dalby T, Petersen JW, Harboe ZB, Krogfelt KA. 2010. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. J. Med. Microbiol. 59:1029-1036.
8. de Greeff SC, et al. 2010. Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 5:e14183. doi:10.1371/journal.pone.0014183.
9. de Greeff SC, et al. 2010. Pertussis disease burden in the household: how to protect young infants. Clin. Infect. Dis. 50:1339-1345.
10. de Melker HE, et al. 2000. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J. Clin. Microbiol. 38:800-806.
11. Edelman K, et al. 2007. Immunity to pertussis 5 years after booster immunization during adolescence. Clin. Infect. Dis. 44:1271-1277. (Pubitemid 46717287)
12. Giammanco A, et al. 2003. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 22:112-120. (Pubitemid 37357158)
13. Guiso N, et al. 2011. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur. J. Clin. Microbiol. Infect. Dis. 30:307-312.
14. Guiso N, et al. 2007. Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Vaccine 25:1390-1397. (Pubitemid 46091822)
15. Hallander HO. 1999. Microbiological and serological diagnosis of pertussis. Clin. Infect. Dis. 28(Suppl 2):S99-S106. (Pubitemid 29270377)
16. Hendrikx LH, et al. 2011. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Vaccine 29:6874-6880.
17. Horby P, et al. 2005. A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiol. Infect. 133: 229-236. (Pubitemid 40439302)
18. Le T, et al. 2004. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J. Infect. Dis. 190:535-544. (Pubitemid 38982093)
19. Marchant CD, et al. 1994. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J. Infect. Dis. 169: 1297-1305. (Pubitemid 24164594)
20. Mertsola J, et al. 2010. Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults. Clin. Infect. Dis. 51:656-662.
21. Nagel J, de Graaf S, Schijf-Evers D. 1985. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. Dev. Biol. Stand. 61:325-330.
22. Nagel J, Poot-Scholtens EJ. 1983. Serum IgA antibody to Bordetella pertussis as an indicator of infection. J. Med. Microbiol. 16:417-426. (Pubitemid 14242533)
23. Pebody RG, et al. 2005. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol. Infect. 133:159-171. (Pubitemid 40276986)
24. Poynten M, Hanlon M, Irwig L, Gilbert GL. 2002. Serological diagnosis of pertussis: evaluation of IgA against whole cell and specific Bordetella pertussis antigens as markers of recent infection. Epidemiol. Infect. 128:161-167. (Pubitemid 34413988)
25. Simondon F, Iteman I, Preziosi MP, Yam A, Guiso N. 1998. Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal. Clin. Diagn. Lab. Immunol. 5:130-134. (Pubitemid 28161179)
26. Teunis PF, et al. 2002. Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiol. Infect. 129:479-489. (Pubitemid 36157671)
27. van der Zee A, Agterberg C, Peeters M, Mooi F, Schellekens J. 1996. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J. Infect. Dis. 174:89-96. (Pubitemid 26255559)
28. Versteegh FG, et al. 2005. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol. Infect. 133:737-748. (Pubitemid 41015566)
29. Ward JI, et al. 2006. Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). Clin. Infect. Dis. 43:151-157.
30. Wirsing von Konig CH, Gounis D, Laukamp S, Bogaerts H, Schmitt HJ. 1999. Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur. J. Clin. Microbiol. Infect. Dis. 18:341-345. (Pubitemid 29531170)
31. Xing D, et al. 2009. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin. Vaccine Immunol. 16:303-311.
32. Yih WK, et al. 2000. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J. Infect. Dis. 182:1409-1416.